コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 with ~ 1000x more energy than the Hiroshima atomic bomb.
2 rent from the whole body radiation after the atomic bombs.
5 ncer risks in a U.S. population derived from atomic bomb-associated cancer mortality data, together w
8 f employment culminated in his work with the Atomic Bomb Casualty Commission on human chromosomes, fo
9 e cancer incidence found in survivors of the atomic bombs dropped in Hiroshima and Nagasaki, the Inte
10 idemiologic cohort study of survivors of the atomic bombs dropped on Hiroshima and Nagasaki, Japan.
11 e relative risks among Japanese survivors of atomic-bomb explosions are greater than those among comp
12 in cultured lymphocytes, of exposure to the atomic bomb in Hiroshima have been reanalyzed to determi
13 s reported thyroid cancer in Japan after the atomic bombs or Chernobyl after the nuclear disaster; di
15 t radiobiologic estimates, based on Japanese atomic bomb survivor data, indicate a substantially high
18 diation doses are reasonably understood from atomic bomb survivor studies, there is much more uncerta
19 study of pregnancy outcomes among births to atomic bomb survivors (Hiroshima and Nagasaki, Japan) wh
20 ions and perinatal deaths in the children of atomic bomb survivors (n = 71,603) using fully reconstru
21 gh-dose cancer risks, based only on data for atomic bomb survivors (who were exposed to lower total d
22 incidence and mortality risk in the Japanese atomic bomb survivors - differences in excess relative a
23 were derived from cancer incidence data for atomic bomb survivors and used to calculate the excess l
24 extending them to populations other than the atomic bomb survivors comes with uncertainty as to gener
27 etic aberration patterns of MN developing in atomic bomb survivors show few mutations in classical DN
28 in the Life Span Study, a study of Japanese atomic bomb survivors who were aged 15-64 years at the t
30 ow-up data through 2002 from 77,752 Japanese atomic bomb survivors, we identified 14,048 participants
31 nd risk models, based mainly on the Japanese atomic bomb survivors, with population-based cancer inci
39 bedded (FFPE) tissues from animals and human atomic-bomb survivors exposed to radioactive particulate
40 incidence and mortality data in the Japanese atomic-bomb survivors were analyzed using relative and a
41 s in the medical series than in the Japanese atomic-bomb survivors, and dose-fractionation effects.
42 On the morning of July 16, 1945, the first atomic bomb was exploded in New Mexico on the White Sand
43 ioactive waste from the effort to develop an atomic bomb was stored in the open near the St Louis, Mi
44 rgely dependent on evidence from exposure to atomic bomb whole body radiation, leading to increases i